Cancell/Cantron/Protocel (PDQ®)–Health Professional Version

Cancell, Cantron, and Protocel have been promoted by its manufacturers as an effective therapy for cancer and other diseases. No animal or human study has been published in a peer-reviewed scientific journal to show safety or effectiveness in treating cancer. Learn more in this clinician summary.


Media Type: Html
  • SourceUrl: https://www.cancer.gov/node/4459/syndication
  • Syndication ID: 1533
  • Language: English
  • Source: National Cancer Institute (NCI)
  • Date Syndication Captured: Saturday, September 14, 2013 at 09:02 AM
  • Date Syndication Updated: Saturday, August 29, 2026 at 01:21 AM

Tags

General: prevention health research policy cessation version professional cancellcantronprotocel secondhand smoke Cancell Smoking Use and Tobacco Facts Quitting Resources Guidance, Regulations and Compliance Prevent Smoking and Tobacco Use

Preview   0 Users liked this content.

Embed Code Snippet


To get the embed code snippet please Login.
Connect With Us

Share on facebook Visit the HHS Twitter account Share on youtube

Share on flickr Share on pinterest Visit HHS GooglePlus account

U.S. Department of Health & Human Services - 200 Independence Avenue, S.W. - Washington, D.C. 20201